EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions
Update: 2025-03-27
Description
Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies.
Read the position paper: Rare primary liver cancers: An EASL position paper
Moderator: Thomas Berg
Faculty: Ruben de Kleine and Henning Wege
Related episodes
- S6E4: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond
- S5E13: Basics in decision-making for liver cancer treatment
- S4 Special Edition 1: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance
All EASL Studio Podcasts are available on EASL Campus.
Click here to see all EASL Video Podcasts on Apple Podcasts.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
